
CancerMedicine
@cancermedicinej
@wileyresearch #openaccess interdisciplinary journal with #global research across the cancer sciences. Editor In Chief Stephen Tait @mitosRus
ID: 1524902718434955277
13-05-2022 00:02:19
191 Tweet
190 Followers
309 Following

CancerMedicine publishes original research articles, systematic reviews, meta-analyses, research methods papers, and brief communications, along with invited editorials and commentaries. #OpenAccess #OncTwitter

ICYMI-Disparities in the care of older adults of color with cancer. Co-authors incl @EAonc Geriatric Oncology WG chair Efrat Dotan MD Fox Chase Cancer Center + Edith P. Mitchell, MD Sidney Kimmel Comprehensive Cancer Center Chair, Health Equity Committee until her passing. CancerMedicine onlinelibrary.wiley.com/doi/10.1002/ca…

Does re-purposing #cardiovascular drugs (e.g. #statins, #NSAIDs, etc.) work in treating #cancer or preventing recurrence? Our CancerMedicine systematic review & meta-analysis found the answer is "no" in most RCTs over the past 20 years. CC: Vinay Prasad MD MPH Alyson Haslam


New research published in ACS Journal Cancer examines the contributing factors associated with differences in #CervicalCancer screening in rural and urban community health centers: ow.ly/UOPv50R3F1S Hyunjung Lee ParichoyPalChoudhury Daniel Wiese Ahmedin Jemal Farhad Islami, MD PhD


📣 Deadline approaching! Cancer Medicine (CancerMedicine), an #OpenAccess journal indexed in Medline and Web of Science, is seeking applications for the role of Associate Editor. 📅 Apply by May 31, 2024. More details below. ow.ly/RKFN50QX2ZU


Happy to share our new publication in CancerMedicine "E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma" onlinelibrary.wiley.com/doi/10.1002/ca…

📣 Last chance! Cancer Medicine (CancerMedicine), an #OpenAccess sound science journal, is seeking applications for the role of Associate Editor. 📅 Deadline: May 31, 2024 Find out how to apply below. ow.ly/x9XB50QX36h


🚨Our latest paper evaluating #proteomic signatures with the Sarculator nomogram to predict high-risk #sarcoma patients is out in CancerMedicine! This is a wonderful collaboration with Sandro Pasquali Rosalba Miceli Alessandro Gronchi Istituto Tumori Read more here dx.doi.org/10.1002/cam4.7…


#Pallonc study in CancerMedicine feat. Alex Chan, PharmD, MPH Enrique Soto Cristiane D Bergerot Ana I. Velázquez Mañana, MD, MSc, FASCO A #globalonc survey by MASCC showing imbalance #LMIC vs #HIC ⚖️ 🔑 issues in #LMIC 💊💰 drug costs 🧭 guideline implementation #HIC: racial/ethnic disparities🧑🦱👱🏿♂️


📝 Just out in CancerMedicine Our paper on Racial and Ethnic Differences in Liver Transplantation and Post–Liver Transplant Survival Among Patients With Hepatocellular Carcinoma. 👉🏽 electronic health record (EHR)-based patient data 👉🏽 2901 patients 👉🏽Racial minorities


#NewPublication from Breffni Hannon Camilla Zimmermann MD PhD and colleagues: "Novel Systemic Anticancer Therapy and Healthcare Utilization at the End of Life: A Retrospective Cohort Study" in CancerMedicine #SupportiveCare #PalliativeMedicine pubmed.ncbi.nlm.nih.gov/39651705/

Our study in CancerMedicine showed an increased risks of CVDs and mortality in cancer patients. onlinelibrary.wiley.com/doi/10.1002/ca…

A recent CancerMedicine study found vulnerable patients are least likely to initiate targeted treatment for prostate cancer and #340B did not improve the rate of patients starting treatment. The 340B program was created to help low-income patients gain access to prescription

🔥 OUR LATEST #OriginalResearch in CancerMedicine on Small Cell Neuroendocrine Carcinoma of the Urinary Tract (SCNEC-URO)👉What drives post-surgical relapse in this aggressive disease? Omar Alhalabi, MD Matt Campbell MD, MS MD Anderson Cancer Center 🔗bit.ly/3E3R7lJ A thread🧵1/




New study in CancerMedicine on perioperative distress in cancer patients! 👉The first month post-op is a critical period 👉Trends vary by cancer type (not a one-size-fits-all approach) This inspired our #SpineNavigators program in an effort to provide targeted support.
